Research & Education

Tumors with ALK rearrangements can harbor more mutations

More research needed to see if treatment should be altered for patients with coexisting mutations

DENVER – The identification of potentially targetable kinase mutations has been an exciting advancement in lung cancer treatment.

Latest research shows careful selection of patients and aggressive intracranial pressure control key to decrease symptoms and prolong survival for patients

Results specific for patients with leptomeningeal carcinomatosis from NSCLC

DENVER – Lung cancer is one of the most common primary cancers that cause leptomeningeal carcinomatosis (LMC), when cancer spreads to the membranes

Lung cancer mortality rates linked to primary care provider density

Study shows mortality surprisingly not linked to thoracic oncology services

DENVER – Lung cancer remains the leading cause of cancer-related deaths and is tied as the third leading cause of death overall in industrialized c

Researchers provide rationale for use of targeted immunotherapy in sarcomatoid lung carcinomas

Find higher levels of programmed death ligand-1 in rare disease

DENVER – Sarcomatoid carcinomas of the lung include rare subtypes of poorly differentiated non–small-cell lung carcinomas of high grade and aggress

Lung cancer mortality rates linked to primary care provider density

Study shows mortality surprisingly not linked to thoracic oncology services

DENVER – Lung cancer remains the leading cause of cancer-related deaths and is tied as the third leading cause of death overall in industrialized c

Researchers provide rationale for use of targeted immunotherapy in sarcomatoid lung carcinomas

Find higher levels of programmed death ligand-1 in rare disease

DENVER – Sarcomatoid carcinomas of the lung include rare subtypes of poorly differentiated non–small-cell lung carcinomas of high grade and aggress

Pages